MoonLake Immunotherapeutics (MEX:MLTXN) Total Current Assets: MXN7,152.51 Mil (As of Mar. 2026)

What is MoonLake Immunotherapeutics Total Current Assets?

MoonLake Immunotherapeutics MEX:MLTXN 30 Total Current Assets is MXN7,152.51 Mil as of Mar. 2026. GuruFocus rates MEX:MLTXN with a GF Score™ of 30/100. The stock has 3 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. MoonLake Immunotherapeutics's total current assets for the quarter that ended in Mar. 2026 was MXN7,152.51 Mil.

MoonLake Immunotherapeutics (MEX:MLTXN) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

MoonLake Immunotherapeutics's Liquidation Value for the quarter that ended in Mar. 2026 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	6454.282	-	2639.086	+	0.75 * 0	+	0.5 * 0
=	3,815.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MoonLake Immunotherapeutics Total Current Assets Related Terms

MoonLake Immunotherapeutics Total Current Assets Historical Data

* Premium members only.

The historical data trend for MoonLake Immunotherapeutics's Total Current Assets can be seen below:

MoonLake Immunotherapeutics Total Current Assets Chart

MoonLake Immunotherapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Dec25

Total Current Assets

197.69

1,491.66

8,727.60

9,891.63

7,592.90

MoonLake Immunotherapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Current Assets	Get a 7-Day Free Trial															10,357.25	8,576.34	7,543.41	7,592.90	7,152.51

30GF Score

MoonLake Immunotherapeutics MEX:MLTXN

Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

MoonLake Immunotherapeutics Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

MoonLake Immunotherapeutics's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	7093.67	+	87.67	+	0	+	411.556
	=	7,592.90

MoonLake Immunotherapeutics's Total Current Assets for the quarter that ended in Mar. 2026 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	6454.282	+	103.922	+	0	+	594.304
	=	7,152.51

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →

What does a Total Current Assets of MXN7,152.51 Mil mean?

MoonLake Immunotherapeutics (MEX:MLTXN) has a Total Current Assets of MXN7,152.51 Mil as of Mar. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for MoonLake Immunotherapeutics and its competitors.

Is MoonLake Immunotherapeutics' Total Current Assets too high?

MoonLake Immunotherapeutics' current Total Current Assets is MXN7,152.51 Mil. Overall, MoonLake Immunotherapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.

How does MoonLake Immunotherapeutics' Total Current Assets compare to AVBP and BCAX?

MoonLake Immunotherapeutics' Total Current Assets of MXN7,152.51 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Current Assets for a Biotechnology company?

A good Total Current Assets depends on the Biotechnology industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Current Assets mean?

A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for MoonLake Immunotherapeutics and its competitors. MoonLake Immunotherapeutics's current Total Current Assets is MXN7,152.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is MoonLake Immunotherapeutics stock overvalued right now?

MoonLake Immunotherapeutics (MEX:MLTXN) has a current Total Current Assets of MXN7,152.51 Mil. The current Total Current Assets is MXN7,152.51 Mil. MoonLake Immunotherapeutics' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Current Assets calculated?

Total Current Assets is calculated from a company's financial statements. For MoonLake Immunotherapeutics (MEX:MLTXN), the current Total Current Assets is MXN7,152.51 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MoonLake Immunotherapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies AVBP BCAX KALV OCS URGN FTRE MAZE SEPN ARDX MPLT VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges MLTX:USA

Address Dorfstrasse 29, Zug, CHE, 6300

Website https://www.moonlaketx.com

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

30GF Score

Get the complete analysis for MEX:MLTXN

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN305.30

Price

View MEX:MLTXN Analysis

See Total Current Assets data for all stocks →